Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 29

1.

Patterns of alcohol consumption and myocardial infarction risk: observations from 52 countries in the INTERHEART case-control study.

Leong DP, Smyth A, Teo KK, McKee M, Rangarajan S, Pais P, Liu L, Anand SS, Yusuf S; INTERHEART Investigators..

Circulation. 2014 Jul 29;130(5):390-8. doi: 10.1161/CIRCULATIONAHA.113.007627.

2.

Diet and kidney disease in high-risk individuals with type 2 diabetes mellitus.

Dunkler D, Dehghan M, Teo KK, Heinze G, Gao P, Kohl M, Clase CM, Mann JF, Yusuf S, Oberbauer R; ONTARGET Investigators..

JAMA Intern Med. 2013 Oct 14;173(18):1682-92.

PMID:
23939297
3.

The effect of chromosome 9p21 variants on cardiovascular disease may be modified by dietary intake: evidence from a case/control and a prospective study.

Do R, Xie C, Zhang X, Männistö S, Harald K, Islam S, Bailey SD, Rangarajan S, McQueen MJ, Diaz R, Lisheng L, Wang X, Silander K, Peltonen L, Yusuf S, Salomaa V, Engert JC, Anand SS; INTERHEART investigators..

PLoS Med. 2011 Oct;8(10):e1001106. doi: 10.1371/journal.pmed.1001106.

4.

Can a heart failure-specific cardiac rehabilitation program decrease hospitalizations and improve outcomes in high-risk patients?

Davidson PM, Cockburn J, Newton PJ, Webster JK, Betihavas V, Howes L, Owensby DO.

Eur J Cardiovasc Prev Rehabil. 2010 Aug;17(4):393-402. doi: 10.1097/HJR.0b013e328334ea56.

PMID:
20498608
5.

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.

Fox K, Ford I, Steg PG, Tendera M, Ferrari R; BEAUTIFUL Investigators..

Lancet. 2008 Sep 6;372(9641):807-16. doi: 10.1016/S0140-6736(08)61170-8.

PMID:
18757088
6.

Telmisartan, ramipril, or both in patients at high risk for vascular events.

ONTARGET Investigators., Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, Anderson C.

N Engl J Med. 2008 Apr 10;358(15):1547-59. doi: 10.1056/NEJMoa0801317.

7.

Soluble low-density lipoprotein receptor-related protein.

Grimsley PG, Quinn KA, Owensby DA.

Trends Cardiovasc Med. 1998 Nov;8(8):363-8.

PMID:
14987551
8.
9.

Characterization of the soluble form of the low density lipoprotein receptor-related protein (LRP).

Quinn KA, Pye VJ, Dai YP, Chesterman CN, Owensby DA.

Exp Cell Res. 1999 Sep 15;251(2):433-41.

PMID:
10471328
10.

Evolutionary conservation of circulating soluble low density lipoprotein receptor-related protein-like ("LRP-like") molecules.

Grimsley PG, Quinn KA, Chesterman CN, Owensby DA.

Thromb Res. 1999 May 1;94(3):153-64.

PMID:
10326762
11.

Low density lipoprotein receptor-related protein (LRP) expression varies among Hep G2 cell lines.

Grimsley PG, Quinn KA, Chesterman CN, Owensby DA.

Thromb Res. 1997 Dec 15;88(6):485-98.

PMID:
9610960
12.

Natural rubber latex hypersensitivity: incidence and prevalence of type I allergy in the dental professional.

Hamann CP, Turjanmaa K, Rietschel R, Siew C, Owensby D, Gruninger SE, Sullivan KM.

J Am Dent Assoc. 1998 Jan;129(1):43-54.

PMID:
9448346
13.

Soluble low density lipoprotein receptor-related protein (LRP) circulates in human plasma.

Quinn KA, Grimsley PG, Dai YP, Tapner M, Chesterman CN, Owensby DA.

J Biol Chem. 1997 Sep 19;272(38):23946-51.

14.

Urokinase binding and catabolism by Hep G2 cells is plasminogen activator inhibitor-1 dependent, analogous to interactions of tissue-type plasminogen activator with these cells.

Grimsley PG, Normyle JF, Brandt RA, Joulianos G, Chesterman CN, Hogg PJ, Owensby DA.

Thromb Res. 1995 Aug 15;79(4):353-61.

PMID:
7482438
16.

Thrombospondin is a tight-binding competitive inhibitor of neutrophil elastase.

Hogg PJ, Owensby DA, Mosher DF, Misenheimer TM, Chesterman CN.

J Biol Chem. 1993 Apr 5;268(10):7139-46.

17.

Endocytosis and lysosomal delivery of tissue plasminogen activator-inhibitor 1 complexes in Hep G2 cells.

Underhill DM, Owensby DA, Morton PA, Schwartz AL.

Blood. 1992 Dec 1;80(11):2746-54.

18.
19.

A crossreactive antipeptide monoclonal antibody with specificity for lysyl-lysine.

Khachigian LM, Evin G, Morgan FJ, Owensby DA, Chesterman CN.

J Immunol Methods. 1991 Jul 5;140(2):249-58. Erratum in: J Immunol Methods 1992 May 18;149(2):267.

PMID:
1712372
20.
Items per page

Supplemental Content

Loading ...
Support Center